Giuseppe Guagliano is a biomedical engineer, with a BSc in Bioengineering from Università Degli Studi di Pavia and a MSc in Biomedical Engineering from Politecnico di Milano with a specialization in cells, tissue engineering, and biotechnology. He is currently a Ph.D. student in Biomedical Engineering at Politecnico di Milano. The main subject of his doctoral project resides in the development of a 3D-bioprinted in vitro model of the liver, to be finally used for the high-throughput screening of drug-induced hepatotoxicity. He is also involved as a core team member in the development of a novel protein-based nanocarrier for drug delivery.